REGN Stock: When Bad News Is Good News
The cross-hairs are pointed directly at the biotechnology sector, as the Donald Trump administration is set to announce its policies on how it will deal with the predatory pricing polices that have tarnished the face of this industry. I have the inclination to believe that this potentially damning news will put a bid towards this sector, and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock. REGN stock is perfectly set up to take advantage of any bullish tailwinds that are created from this news,.
Den vollständigen Artikel lesen ...
The cross-hairs are pointed directly at the biotechnology sector, as the Donald Trump administration is set to announce its policies on how it will deal with the predatory pricing polices that have tarnished the face of this industry. I have the inclination to believe that this potentially damning news will put a bid towards this sector, and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock. REGN stock is perfectly set up to take advantage of any bullish tailwinds that are created from this news,.
Den vollständigen Artikel lesen ...